IgA nephropathy trials in Greece

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials

  Where

  Chaïdári, Ioannina, Kalamaria, Patras, Thessaloniki

  Age

  18 years and over

  People

  69 worldwide

  Run by

  Novartis Pharma AG

  See details and how to join2024-519638-22-00 · EU 2024-519638-22-00
• Phase 3Taking people
  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  Where

  Arta, Athens, Chaïdári, Heraklion, Ioannina, Patras, Thessaloniki

  Age

  18 years and over

  People

  454 worldwide

  Run by

  Biogen

  See details and how to joinNCT06935357 · EU 2024-519345-30-00
• Phase 2/3Enrolling by invitation
  Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

  Where

  Heraklion

  Age

  18 years and over

  People

  600 worldwide

  Run by

  Otsuka Pharmaceutical Development & Commercialization, Inc.

  See details and how to joinNCT05248659